
Del Smith & Tiffany Whitlow
Acclinate
Acclinate aims to integrate culture and technology to drive inclusive clinical research by helping pharmaceutical companies and healthcare organizations access and engage communities of color.
Year invested
2022
Industry
Access Innovation
Why Inclusive clinical research?
Longstanding inequities in research and clinical trials presents an opportunity to ensure the voices of all ethnic groups are represented in the clinical trials for medical solutions that impact their communities. When medicines and therapeutic trials do not have representative samples from the population, it increases the likelihood that these medications will have varying levels of effectiveness when administered across populations.